EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
Further deduction for Coronavirus Disease 2019 (COVID-19) screening costs borne by employers
As highlighted in an earlier alert, the Income Tax (Deduction for Expenses in relation to the Cost of Detection Test of Coronavirus Disease 2019 (COVID-19) for Employees) Rules 2021 were gazetted to provide that in ascertaining a Malaysian-resident employer’s adjusted income from his business for a YA, there shall be allowed a further deduction (i.e., a deduction in addition to any deduction allowable under Section 33 of the ITA) for the cost of COVID-19 detection tests for his employees between 1 January 2021 and 31 December 2021 (see Tax Alert No. 22/2021). In order to qualify for the additional deduction, the employer has to produce a receipt and certification issued by a medical practitioner registered with the Malaysian Medical Council or a medical practitioner registered outside Malaysia, indicating that the COVID-19 detection tests had been provided to his employees.
Following the above, the Income Tax (Deduction for Expenses in relation to the Cost of Detection Test of Coronavirus Disease 2019 (COVID-19) for Employees) (Amendment) Rules 2022 [P.U.(A) 291] were gazetted on 9 September 2022 to provide that:
The receipt and certification issued by a medical practitioner registered outside Malaysia apply only to expenses incurred outside Malaysia, and
As an alternative, to qualify for the additional deduction, employers may also produce receipts and COVID-19 detection test results of their employees issued by a health facility listed in the List of Laboratories Conducting RT-PCR Test for COVID-19 to the COVID-19 Management Guidelines in Malaysia No. 5/2020 (refer to Annex 4a) issued by the Ministry of Health Malaysia.